Stay updated on GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial
Sign up to get notified when there's something new on the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page.

Latest updates to the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed in the Record History, reflecting a minor site-version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check15 days agoChange DetectedNew revision entry v3.4.1 added to the record history. The older government funding notice/banner was removed.SummaryDifference0.9%

- Check22 days agoChange DetectedA global site notice about a lapse in government funding was added at the top, indicating that information may not be up to date and that the NIH Clinical Center is open, with links for status updates.SummaryDifference0.8%

- Check29 days agoChange DetectedThe record history page adds a glossary display option, color-coded highlights for additions (green) and deletions (red), and shows the revision version (v3.4.0).SummaryDifference1%

- Check36 days agoChange DetectedThe page history shows an added Revision: v3.3.4 and a removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page history shows a new Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link in the footer. The core study content and status appear unchanged.SummaryDifference0.2%

Stay in the know with updates to GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page.